BIORESTORATIVE THERAPIES, INC.: net finite-lived intangible assets

What this measure means

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

Exact concept: us-gaap:FiniteLivedIntangibleAssetsNet. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2012-04-06 to 2025-12-31. The SEC response was captured on 2026-09-19.

Selected filing history

Related financial histories

• BIORESTORATIVE THERAPIES, INC.: total assets
• BIORESTORATIVE THERAPIES, INC.: total liabilities
• BIORESTORATIVE THERAPIES, INC.: stockholders equity
• BIORESTORATIVE THERAPIES, INC.: cash and cash equivalents
• BIORESTORATIVE THERAPIES, INC.: net income or loss
• BIORESTORATIVE THERAPIES, INC.: operating cash flow
• BIORESTORATIVE THERAPIES, INC.: capital expenditure payments
• BIORESTORATIVE THERAPIES, INC.: revenue
• BIORESTORATIVE THERAPIES, INC.: contract revenue excluding tax
• BIORESTORATIVE THERAPIES, INC.: financing cash flow
• BIORESTORATIVE THERAPIES, INC.: investing cash flow
• BIORESTORATIVE THERAPIES, INC.: retained earnings or deficit
• BIORESTORATIVE THERAPIES, INC.: basic weighted-average shares
• BIORESTORATIVE THERAPIES, INC.: diluted weighted-average shares
• BIORESTORATIVE THERAPIES, INC.: basic earnings per share
• BIORESTORATIVE THERAPIES, INC.: diluted earnings per share
• BIORESTORATIVE THERAPIES, INC.: net property, plant and equipment
• BIORESTORATIVE THERAPIES, INC.: share-based compensation expense
• BIORESTORATIVE THERAPIES, INC.: operating income or loss
• BIORESTORATIVE THERAPIES, INC.: current assets
• BIORESTORATIVE THERAPIES, INC.: interest expense
• BIORESTORATIVE THERAPIES, INC.: current liabilities
• BIORESTORATIVE THERAPIES, INC.: current accounts payable
• BIORESTORATIVE THERAPIES, INC.: net current accounts receivable
• BIORESTORATIVE THERAPIES, INC.: common-stock repurchase payments
• BIORESTORATIVE THERAPIES, INC.: operating expenses
• BIORESTORATIVE THERAPIES, INC.: net inventory
• BIORESTORATIVE THERAPIES, INC.: gross profit
• BIORESTORATIVE THERAPIES, INC.: research and development expense

Inspect the source

Entity

BIORESTORATIVE THERAPIES, INC. / CIK 0001505497

Captured

2026-09-19T11:18:28.483Z

SEC response SHA-256

fd60c78bee3335eafd56c883fed2689ce9a2b29ba609bffc874788f5f89f9708

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001505497.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))